Gram-negative bacteremia.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria; D001442:Bacteroides Infections / Q000175:diagnosis; D002473:Cell Wall / Q000032:analysis; D003428:Cross Infection / Q000209:etiology*; D004352:Drug Resistance, Microbial; D004731:Endotoxins / Q000032:analysis / Q000494:pharmacology; D004754:Enterobacter; D004756:Enterobacteriaceae Infections / Q000175:diagnosis; D004927:Escherichia coli Infections / Q000209:etiology*; D005334:Fever / Q000209:etiology; D006801:Humans; D007710:Klebsiella Infections / Q000175:diagnosis; D008070:Lipopolysaccharides / Q000032:analysis; D011512:Proteus Infections / Q000175:diagnosis; D011552:Pseudomonas Infections / Q000175:diagnosis; D011749:Pyrogens; D018805:Sepsis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D012772:Shock, Septic / Q000175:diagnosis; D012790:Shwartzman Phenomenon / Q000209:etiology
D000900:Anti-Bacterial Agents; D004731:Endotoxins; D008070:Lipopolysaccharides; D011749:Pyrogens